Litcius/Paper detail

Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience

V. Espírito Santo, João Passos, Hipólito Nzwalo, Inês Carvalho, Filipa Santos, Carmo Martins, Lucília Salgado, Conceição e Silva, Sofia Vinhais, Miguel Vilares, Duarte Salgado, Sofia Nunes

2020Journal of Neuro-Oncology56 citationsDOI

Topics & Concepts

SelumetinibMedicineNeurofibromatosisAdverse effectDisfigurementNeurofibromatosis type IInternal medicineOncologySurgeryPathologyCancerKRASColorectal cancerNeurofibromatosis and Schwannoma CasesMelanoma and MAPK PathwaysTuberous Sclerosis Complex Research
Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience | Litcius